SKSamet Kurnaz

Samet Kurnaz

*This is an algorithmically generated author record based on publicly available information.

Samet Kurnaz has a total of 13 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The possible link between endocannabinoid system gene polymorphisms and overweight/obesity susceptibility in individuals living in the Marmara Region

    by Beril Altun, İsMet Cok, Cemal Onur Noyan, Ela Kadioglu, Alptekin Cetin, Tijen Sengezer, Merih Altintas, Samet Kurnaz, Nesrin Dilbaz

    Objectives: Obesity is a global health problem related to reduced life quality and shorter life expectancy. Given the fact that genetic factors play a role in obesity development, studies have suggested that polymorphisms of cannabinoid receptor 1 ( CNR1 ), monoacylglycerol lipase ( MGLL ), and fatty acid amide hydrolase ( FAAH ) genes located in the endocannabinoid system (ECS) are related to overweight/obesity risk. Accordingly, we aimed to assess the genetic susceptibility to overweight/obesity in individuals with Turkish ancestral origin concerning these ECS genes. Methods: The present study comprised 194 unrelated individuals with Turkish ancestral origin living in the Marmara Region. The study population is categorized into two groups according to their body mass index (BMI) overweight/obese group (BMI≥25) and normal weight group (18.5CNR1 rs1049353 , MGLL rs60430 , and FAAH rs324420 polymorphisms was performed using the real-time polymerase chain reaction (RT-PCR). Results: The GG genotype frequency of CNR1 rs1049353 was significantly higher in overweight/obese individuals than in normal weight individuals (75.5 vs. 61.4 %, respectively; p=0.034). No difference was observed in terms of MGLL rs604300 and FAAH rs324420 polymorphisms between the groups (p>0.05). The genotype distributions of CNR1 , MGLL , and FAAH genes were compatible with the Hardy–Weinberg equilibrium (p>0.05). Conclusions: Our findings supported that individuals with AA/AG genotype of CNR1 rs1049353 have reduced overweight/obesity risk; however, neither FAAH rs324420 nor MGLL rs604300 showed any association. A relatively smaller sample size and lack of inclusion of obesity-related measurements could be considered the limitations of this study. Further research is needed to confirm or disprove our results.


  • Open Access

    Assessment of the effects of CNR1, FAAH and MGLL gene variations on the synthetic cannabinoid use disorder

    by Beril Altun, Ismet Cok, Cemal Onur Noyan, Ela Kadioglu, Alptekin Cetin, Tijen Sengezer, Merih Altintas, Samet Kurnaz, Nesrin Dilbaz

    Objectives: Given that drug addiction occurs as a result of complex gene-environment interaction, a number of studies claimed that cannabinoid receptor 1 ( CNR1 ), fatty acid amide hydrolase ( FAAH ), and monoacylglycerol lipase ( MGLL ) single nucleotide polymorphisms (SNPs) are associated with the risk of substance use disorders such as cannabis, opioids, and, methamphetamine. However, scientific research on genetic susceptibility to synthetic cannabinoid addiction is limited. In this population-based case-control study, we aimed to evaluate the genetic susceptibility to synthetic cannabinoid use disorder in terms of these three endocannabinoid system genes in the Turkish population. Methods: 100 individuals diagnosed with synthetic cannabinoid use disorder according to Diagnostics and Statistical Manual of Mental Disorders-5 criteria and 100 healthy volunteers have recruited for the study. Genotyping of the CNR1 rs1049353 , FAAH rs324420 , and MGLL rs604300 SNPs was performed using Real-Time Polymerase Chain Reaction hybridization probes. Results: The patient and control groups consist of 98 % male, 2 % female, 80 % male, and 20 % female individuals, respectively. The genotype distributions were consistent with Hardy–Weinberg equilibrium for all SNPs (p>0.05). FAAH rs324420 and MGLL 604300 SNPs were genotyped for the first time in the Turkish population, and the variant allele frequencies were found as 0.205 and 0.085, respectively. Allele frequencies and genotype distributions CNR1 rs1049353 , FAAH rs324420 , and MGLL rs604300 SNPs were similar between the patient and control group (p>0.05). Conclusions: These results indicate that CNR1 , FAAH , and MGLL gene polymorphisms do not influence the risk of synthetic cannabinoid use disorder in the Turkish population.


  • Cannabis use and first onset Schizophrenia-like psychosis after traumatic brain injury in a patient with intracranial bullet

    by Mine Ergelen, Murat Yalçın, Fikret Ferzan Gıynaş, Samet Kurnaz, Nazife Gamze Usta Saglam

    Traumatic brain injury (TBI) is an important cause of mortality and morbidity worldwide. Cannabis use disorder and psychosis are rare but serious comorbidities seen after TBI. Recent studies indicate that the use of cannabis for self-medication may increase after TBI. Schizophrenia-like psychosis (SLP) is also seen, generally showing a late and gradual onset after TBI. Especially in case of cannabis use disorder, post-TBI psychosis may develop earlier than expected and cause difficulties in terms of diagnosis. In this report, a middle-aged female patient started using cannabis to relieve her anxiety symptoms, six months after a TBI secondary to gunshot wounding, and developed psychotic symptoms within two months. We document her admission, detoxification and recovery during an inpatient stay in the Alcohol and Drug Addiction Research, Treatment and Education Center (AMATEM) inpatient unit. We aim to emphasize the importance of follow-up of patients after TBI in terms of neuropsychiatric symptoms and initiation of symptomatic treatment.